Open access · CC-BY
via OpenAlex
Fate decision of mesenchymal stem cells: adipocytes or osteoblasts?
Qing Chen, Peishun Shou, C Zheng, Mengmeng Jiang, G Cao, Qiaolin Yang, J Cao, N Xie, Tania Velletri, X Zhang, Chunsheng Xu, L Zhang, Haiyan Yang, Jie Hou, Ying Wang
Cell Death and Differentiation · 2016 · ▲ 1,327 citations
Stem-cell exhaustion
Altered intercellular communication
Stem-cell therapy
Cell culture / in vitro
In vitro
Review
Abstract
Mesenchymal stem cells (MSCs), a non-hematopoietic stem cell population first discovered in bone marrow, are multipotent cells capable of differentiating into mature cells of several mesenchymal tissues, such as fat and bone. As common progenitor cells of adipocytes and osteoblasts, MSCs are delicately balanced for their differentiation commitment. Numerous in vitro investigations have demonstrated that fat-induction factors inhibit osteogenesis, and, conversely, bone-induction factors hinder adipogenesis. In fact, a variety of external cues contribute to the delicate balance of adipo-osteogenic differentiation of MSCs, including chemical, physical, and biological factors. These factors trigger different signaling pathways and activate various transcription factors that guide MSCs to commit to either lineage. The dysregulation of the adipo-osteogenic balance has been linked to several pathophysiologic processes, such as aging, obesity, osteopenia, osteopetrosis, and osteoporosis. Thus, the regulation of MSC differentiation has increasingly attracted great attention in recent years. Here, we review external factors and their signaling processes dictating the reciprocal regulation between adipocytes and osteoblasts during MSC differentiation and the ultimate control of the adipo-osteogenic balance.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1038/cdd.2015.168
- Canonical
- link ↗
- Fetched
- 2026-09-28 MST
Cite this
APA
Chen, Q., Shou, P., Zheng, C., Jiang, M., Cao, G., Yang, Q., Cao, J., Xie, N., Velletri, T., Zhang, X., Xu, C., Zhang, L., Yang, H., Hou, J., Wang, Y., & Shi, Y. (2016). Fate decision of mesenchymal stem cells: adipocytes or osteoblasts?. <em>Cell Death and Differentiation</em>. https://doi.org/10.1038/cdd.2015.168
Vancouver
Chen Q, Shou P, Zheng C, Jiang M, Cao G, Yang Q, et al. Fate decision of mesenchymal stem cells: adipocytes or osteoblasts?. Cell Death and Differentiation. 2016. doi:10.1038/cdd.2015.168.
BibTeX
@article{qing2016Fatede,
title = {Fate decision of mesenchymal stem cells: adipocytes or osteoblasts?},
author = {Qing Chen and Peishun Shou and C Zheng and Mengmeng Jiang and G Cao and Qiaolin Yang and J Cao and N Xie and Tania Velletri and X Zhang and Chunsheng Xu and L Zhang and Haiyan Yang and Jie Hou and Ying Wang and Yufang Shi},
journal = {Cell Death and Differentiation},
year = {2016},
doi = {10.1038/cdd.2015.168},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Stem Cell Research & Therapy 2020
Open access · CC-BY
Mesenchymal stem cells: amazing remedies for bone and cartilage defects
Tissue and Cell 2011
Citation only
Growth factors and chondrogenic differentiation of mesenchymal stem cells
Cell Communication and Signaling 2011
Open access · CC-BY
Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC
Regenerative Therapy 2018
Open access · CC-BY
Aging of mesenchymal stem cells: Implication in regenerative medicine
Stem Cell Research & Therapy 2024
Open access · CC-BY
Translational potential of mesenchymal stem cells in regenerative therapies for human diseases: challenges and opportunities
Journal of Cellular and Molecular Medicine 2010
Open access · OA